| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8459282 | Radiotherapy and Oncology | 2018 | 7 Pages |
Abstract
Prediction of Xer12m was significantly improved with pre-treatment PET-IBMs, indicating that high metabolic parotid gland activity is associated with lower risk of developing late xerostomia. This study highlights the potential of incorporating patient-specific PET-derived functional characteristics into NTCP model development.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Lisanne V. van Dijk, Walter Noordzij, Charlotte L. Brouwer, Ronald Boellaard, Johannes G.M. Burgerhof, Johannes A. Langendijk, Nanna M. Sijtsema, Roel J.H.M. Steenbakkers,